Copyright
©The Author(s) 2017.
World J Gastroenterol. Nov 7, 2017; 23(41): 7415-7424
Published online Nov 7, 2017. doi: 10.3748/wjg.v23.i41.7415
Published online Nov 7, 2017. doi: 10.3748/wjg.v23.i41.7415
Table 4 Survival rates of hepatocellular carcinoma patients in different groups
| Group | OS rate (%) | RFS rate (%) | ||||||||
| 1 yr | 2 yr | 3 yr | 4 yr | P | 1 yr | 2 yr | 3 yr | 4 yr | P | |
| MVI (-), TACE (-) | 98.8 | 91.5 | 82.8 | 82.8 | 0.872 | 80.7 | 70.1 | 61.2 | 55.9 | 0.974 |
| MVI (-), TACE (+) | 94.2 | 91.9 | 87.6 | 87.6 | 83.0 | 71.8 | 61.9 | NA | ||
| MVI (+), TACE (-) | 81.3 | 65.7 | 58.8 | 53.9 | 0.019 | 52.0 | 41.1 | 33.7 | 28.4 | 0.002 |
| MVI (+), TACE (+) | 92.7 | 86.5 | 73.1 | 67.5 | 72.1 | 58.3 | 54.9 | 30.9 | ||
- Citation: Ye JZ, Chen JZ, Li ZH, Bai T, Chen J, Zhu SL, Li LQ, Wu FX. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion. World J Gastroenterol 2017; 23(41): 7415-7424
- URL: https://www.wjgnet.com/1007-9327/full/v23/i41/7415.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i41.7415